{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:37:48Z","timestamp":1790775468366,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.brainresbull.2018.02.007","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T18:46:56Z","timestamp":1517942816000},"page":"114-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways"],"prefix":"10.1016","volume":"139","author":[{"given":"Benneth","family":"Ben-Azu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itivere Adrian","family":"Omogbiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adegbuyi Oladele","family":"Aderibigbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Umukoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abayomi Mayowa","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezekiel O.","family":"Iwalewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2018.02.007_bib0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00210-017-1386-z","article-title":"Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice","volume":"390","author":"Annafi","year":"2017","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nn1609","article-title":"Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse","volume":"9","author":"Aoyama","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/157015911795596504","article-title":"Schizophrenia: redox regulation and volume neurotransmission","volume":"9","author":"B\u00f3kkon","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0020","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1016\/j.jalz.2011.05.1329","article-title":"Cognitive improvement and anti-amyloidogenic effect of doxycycline in a double transgenic mouse model of Alzheimer disease","volume":"7","author":"Balducci","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","article-title":"Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia: prog","volume":"27","author":"Becker","year":"2003","journal-title":"Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuropharm.2009.06.002","article-title":"Does schizophrenia arise from oxidative dysregulation of parvalbumin interneurons in the developing cortex?","volume":"57","author":"Behrens","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0035","doi-asserted-by":"crossref","first-page":"13957","DOI":"10.1523\/JNEUROSCI.4457-08.2008","article-title":"Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia","volume":"28","author":"Behrens","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4236\/jbbs.2016.613048","article-title":"Doxycycline ameliorates schizophrenia-Like behaviors in experimental models in mice by targeting underlying oxidative stress","volume":"6","author":"Ben-Azu","year":"2016","journal-title":"JBBS"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0045","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1080\/13880209.2016.1190382","article-title":"Neuroprotective effects of the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced schizophrenia-like behaviors and oxidative damage in mice","volume":"54","author":"Ben-Azu","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2005.05.019","article-title":"The many faces of nitric oxide in schizophrenia. A review","volume":"78","author":"Bernstein","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","article-title":"Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons","volume":"16","author":"Braidy","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","article-title":"Immune system to brain signaling: neuropsychopharmacological implications","volume":"130","author":"Capuron","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbadis.2006.01.008","article-title":"Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice","volume":"1762","author":"Casadesus","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0070","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neuropharm.2012.05.041","article-title":"Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice","volume":"63","author":"Chatterjee","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0075","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11064-011-0670-4","article-title":"Evaluation of the antipsychotic potential of Panax quinquefolium in ketamine induced experimental psychosis model in mice","volume":"37","author":"Chatterjee","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pnpbp.2012.04.018","article-title":"Ketamine enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia","volume":"38","author":"Chindo","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0085","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.bjp.0704315","article-title":"Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant \u03b17 and \u03b14\u03b22 neuronal nicotinic acetylcholine receptors in Xenopus oocytes","volume":"134","author":"Coates","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0090","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1523\/JNEUROSCI.2614-05.2005","article-title":"Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration","volume":"25","author":"Cunningham","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainresbull.2010.05.011","article-title":"Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice","volume":"8","author":"da Silva","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpsychires.2016.09.017","article-title":"Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs","volume":"84","author":"da Silva","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","article-title":"Determination of serum protein by means of Biuret Reaction","volume":"177","author":"Gornall","year":"1949","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.6451927","article-title":"Nitrate synthesis in the germ free and conventional rat","volume":"212","author":"Green","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0125","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamapsychiatry.2013.1292","article-title":"Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized double-blind, placebo-controlled trial","volume":"70","author":"Hallak","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0920-9964(00)00169-9","article-title":"Red blood cell nitric oxide levels in patients with schizophrenia","volume":"52","author":"Herken","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0135","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.neuint.2012.08.006","article-title":"Effects of the putative antipsychotic alstonine on glutamate uptake in acute hippocampal slices","volume":"61","author":"Herrmann","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0140","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0091-3057(91)90571-I","article-title":"Ketamine-induced hyperlocomotion associated with alteration of presynaptic component of dopamine neurons in the nucleus accumbens of mice","volume":"40","author":"Irifune","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0145","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s11064-007-9315-z","article-title":"Modulation of [3H]dopamine release by glutathione in mouse striatal slices","volume":"32","author":"Janaky","year":"1981","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1981","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.schres.2010.07.001","article-title":"Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data","volume":"122","author":"Jia","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000136485","article-title":"Bromobenzene-induced liver necrosis. Protective role of glutathione an evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite","volume":"11","author":"Jollow","year":"1974","journal-title":"Pharmacology"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10787-011-0077-5","article-title":"Anti-inflammatory properties of doxycycline and minocycline in experimental models: an In Vivo and In Vitro comparative study","volume":"19","author":"Leite","year":"2011","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(00)00111-2","article-title":"Catching up on schizophrenia: natural history and neurobiology","volume":"28","author":"Lewis","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","article-title":"A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia","volume":"71","author":"Levkovitz","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fncel.2017.00181","article-title":"Glutamate deregulation in ketamine-induced psychosis\u2014a potential role of PSD95, NMDA receptor and PMCA interaction","volume":"11","author":"Lisek","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnmol.2016.00019","article-title":"Molecular mechanisms regulating LPS-induced inflammation in the brain","volume":"9","author":"Lykhmus","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0190","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jpsychires.2013.06.008","article-title":"Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration","volume":"47","author":"Mello","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.mp.4001193","article-title":"Clozapine-induced reduction of glutamate transport in the frontal cortex is not mediated by GLAST and EAAC1","volume":"8","author":"Melone","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0200","series-title":"Basic & Clinical Pharmacology","article-title":"Antipsychotic agents & lithium","author":"Meltzer","year":"2010"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0205","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","article-title":"The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase","volume":"247","author":"Misra","year":"1972","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/WNF.0b013e3181593d45","article-title":"Minocycline as adjunctive therapy for schizophrenia: an open-label study","volume":"31","author":"Miyaoka","year":"2008","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0215","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0225","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1177\/0269881113503506","article-title":"Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: possible involvement of antioxidant and nitrergic pathway","volume":"11","author":"Monte","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0230","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1124\/mol.106.032961","article-title":"Involvement of a dysfunctional sopamine-D1\/N-methyl-d-aspartate- NR1 and Ca2 \u00fe\/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine","volume":"71","author":"Mouri","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0235","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","article-title":"Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism","volume":"128","author":"Neill","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0240","first-page":"5","article-title":"The neurobiology of depression: inroads to treatment and new drug discovery","volume":"66","author":"Nemeroff","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0245","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S1461145707008401","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implications","volume":"11","author":"Ng","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0250","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.pbb.2011.02.025","article-title":"Doxycycline protects against pilocarpine-induced convulsions in rats, through its antioxidant effect and modulation of brain amino acids","volume":"98","author":"Nogueira","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0255","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Okhawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0260","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1515\/jbcpp-2012-0073","article-title":"Jobelyn pretreatment ameliorates symptoms of psychosis in experimental models","volume":"24","author":"Omogbiya","year":"2013","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0265","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s00213-017-4666-x","article-title":"Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono- or adjunct therapy","volume":"234","author":"Onaolapo","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0270","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.biopha.2017.05.094","article-title":"Melatonin attenuates behavioural deficits and reduces brain oxidative stress in a rodent model of schizophrenia","volume":"92","author":"Onaolapo","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0275","first-page":"96","article-title":"Neuroprotective effect of pterostilbene on ketamine induced schizophrenia in mice","volume":"1","author":"Palsa","year":"2016","journal-title":"Int. J. Appl. Pharm."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0280","first-page":"157","article-title":"Oxidative stress as marker of positive symptoms in schizophrenia","volume":"9","author":"Pavlovic","year":"2002","journal-title":"Facta Univ."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0285","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1440-1819.2009.02015.x","article-title":"Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile","volume":"63","author":"Pazvantoglu","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0290","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0295","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1601-183X.2009.00487.x","article-title":"Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit","volume":"8","author":"Radyushkin","year":"2009","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0300","doi-asserted-by":"crossref","first-page":"e0175195","DOI":"10.1371\/journal.pone.0175195","article-title":"Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure","volume":"12","author":"Riba","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2013.10.040","article-title":"Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine","volume":"151","author":"Ribeiro","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0310","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2005.08.029","article-title":"A pharmacological model of psychosis based on N-methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities","volume":"59","author":"Rujescu","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0315","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0320","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-0102(99)00120-0","article-title":"Lithium plus pilocarpine induced status epilepticus-biochemical changes","volume":"36","author":"Simoni\u00e9","year":"2000","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0325","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0003-2697(72)90132-7","article-title":"Colorimetric assay of catalase","volume":"47","author":"Sinha","year":"1971","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0330","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s002130100860","article-title":"Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients","volume":"158","author":"Srivastava","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0335","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2045125314557797","article-title":"Drug models of schizophrenia","volume":"5","author":"Steeds","year":"2015","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0340","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brainresbull.2017.04.002","article-title":"Methyl jasmonate attenuates memory dysfunction and decreases brain levels of biomarkers of neuroinflammation induced by lipopolysaccharide in mice","volume":"131","author":"Umukoro","year":"2017","journal-title":"Brian Res. Bull."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0345","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/glia.20172","article-title":"Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures","volume":"50","author":"Vallejo-Illarramendi","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0350","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.schres.2015.04.017","article-title":"Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice Participation of antioxidant, nitrergic and neurotrophic mechanisms","volume":"165","author":"Vasconcelos","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0355","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/157015911795016912","article-title":"Impaired spatial memory after ketamine administration in chronic low doses","volume":"9","author":"Ven\u00e2ncioa","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0360","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","article-title":"Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"37","author":"Vinay","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0365","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1152\/jn.2000.83.4.1796","article-title":"Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons In Vivo","volume":"83","author":"West","year":"2000","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0370","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11427-010-0013-8","article-title":"A meta-analysis of oxidative stress markers in schizophrenia","volume":"53","author":"Zhang","year":"2010","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0375","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.neuropharm.2011.12.014","article-title":"Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia","volume":"62","author":"Zhang","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2018.02.007_bib0380","doi-asserted-by":"crossref","first-page":"93966","DOI":"10.1371\/journal.pone.0093966","article-title":"Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923017306020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923017306020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:29:32Z","timestamp":1759782572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923017306020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":76,"alternative-id":["S0361923017306020"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2018.02.007","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2018.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}